![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/04 | (2006.01) |
C07D 401/04 | (2013.01) | ||
A61K 31/4545 | (2006.01) |
(11) | Number of the document | 3853217 |
(13) | Kind of document | T |
(96) | European patent application number | 19862150.0 |
Date of filing the European patent application | 2019-09-18 | |
(97) | Date of publication of the European application | 2021-07-28 |
(45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2019/106433 |
Date | 2019-09-18 |
(87) | Number | WO 2020/057549 |
Date | 2020-03-26 |
(30) | Number | Date | Country code |
201862732994 P | 2018-09-18 | US |
(72) |
CHEN, Xiangyang , CN
WANG, Zuopeng , CN
YU, Liqin , CN
|
(73) |
Beijing InnoCare Pharma Tech Co., Ltd. ,
Bldg. 8, Community No. 1
No. 8 Courtyard, Life Park Road
ZGC Life Science Park
Changping District, Beijing 102206,
CN
|
(54) | CRYSTALLINE FORM OF 6-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL) NICOTINAMIDE |
CRYSTALLINE FORM OF 6-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL) NICOTINAMIDE |